Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Antigen</td><td align="center">Estimate %</td><td align="center">95% CI</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">fHbp</td><td align="center">2.1</td><td align="center">1.4–3.1</td></tr><tr><td align="left">NHBA</td><td align="center">29.4</td><td align="center">16.9–51.1</td></tr><tr><td align="left">NadA</td><td align="center">0.9</td><td align="center">0.4–1.9</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Positive bacterial threshold (PBT) values with 95% CIs for three antigens [<a href="/journals/jir/2015/353461/#B26">26</a>].

Journal of Immunology Research

tab1

Table 1

Table 1: Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes 

Table 1 | Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes 